Medical research charity sector priorities for a new Government
4 May 2017
Ahead of the publication of general election manifestos by the key political parties, AMRC has written to the manifesto authors of the four main parties –the Conservative Party, the Labour Party, the Liberal Democrats, and the Scottish National Party. This document outlines the key priorities that the medical research charity sector is called for from a new Government.
'Building our Industrial Strategy' response
24 April 2017
AMRC are members of the Life Sciences Industrial Strategy Board. We have fed in our thoughts to inform the development of the Life Sciences Industrial Strategy.
4 April 2017
Supporter members are organisations operating in the medical research sector with an interest in the activities of AMRC and our members.
AMRC Response: Commons Science and Technology Committee inquiry on research integrity
27 March 2017
AMRC responds to the Commons Science and Technology Committee inquiry on research integrity
AMRC Response: HEFCE Research Excellence Framework Consultation
10 March 2017
AMRC responds to HEFCE Research Excellence Framework Consultation
AMRC Response: NICE public involvement review consultation
1 March 2017
AMRC responds to NICE public involvement review consultation
Public Affairs Officer Job Description
23 February 2017
This is an exciting role to increase the impact of AMRC’s public affairs work, supporting the policy and public affairs team and engaging with our members to coordinate effective public affairs and media responses.
Policy Officer Job Description 2017
21 February 2017
This is an exciting opportunity to be part of a small but highly-influential policy and public affairs team at the heart of the medical research community. You will work with other members of the team and engage with our member charities to develop and communicate AMRC policy.
AMRC response to NICE and NHS E Consultation on Health Technology Appraisal
16 February 2017
AMRC's response to NICE and NHS England's proposals for changes to the arrangements for evaluating and funding drugs and other health technologies appraised through NICE’s Technology Appraisal and Highly Specialised Technologies programmes.
Draft agenda - Impact and evaluation masterclass 14.3.17
14 February 2017
Draft agenda for Impact and evaluation masterclass taking place 14 March 2017